There have been published reports of preclinical data in immune competent models of myeloma, melanoma, and mesothelioma in which VSV-IFNβ infection results in CD8+ mediated tumor cytotoxicity [5, 17, 18]. This evidence concerns the gene CD8A and mesothelioma.